This inventor holds 1 USPTO granted patent. Top assignee: Cellectis S.a.. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: Inventor Jean-Stephane Joly: Innovating Genetic Engineering
Introduction
Jean-Stephane Joly is an accomplished inventor based in Versailles, France. He has made significant contributions to the field of genetic engineering, holding a valuable patent that demonstrates his innovative approach to biotechnology.
Latest Patents
Joly holds a patent for his invention titled "Random integration of a polynucleotide by in vivo linearization." This inventive method concerns the in vivo generation of a linear polynucleotide with free ends, which is crucial for successful integration into the host cell genome. The method utilizes a vector that does not possess free ends, ensuring that the polynucleotide to be linearized is flanked by a unique cleavage site. Importantly, this cleavage site is not found in the host cell genome, facilitating precise genetic modifications. The implications of this invention extend to the production of proteins, genes, biomaterials, transgenic plants, and vaccines, making it pivotal for various applications in medical and agricultural fields.
Career Highlights
Jean-Stephane Joly is associated with Cellectis S.A., a company renowned for its pioneering work in genetic engineering and cell therapies. His role at Cellectis highlights his dedication to advancing biotechnological innovations that can lead to significant breakthroughs in healthcare.
Collaborations
Throughout his career, Joly has collaborated with notable professionals in the field, including Andre Choulika and Violette Thermes. These collaborations reflect a shared commitment to innovation and have contributed to the enhancement of research and development in the area of genetic engineering.
Conclusion
Jean-Stephane Joly's contributions to the field of biotechnology through his inventive patent and collaborative efforts illustrate his role as a pioneering inventor. His innovative methods promise to open new avenues for research and applications that could have a profound impact on medicine and agriculture, showcasing the importance of continuous advancement in technology.